Ben Watson

619 total citations
13 papers, 433 citations indexed

About

Ben Watson is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, Ben Watson has authored 13 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 5 papers in Pharmacology and 4 papers in Cognitive Neuroscience. Recurrent topics in Ben Watson's work include Neuroscience and Neuropharmacology Research (7 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Cannabis and Cannabinoid Research (3 papers). Ben Watson is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Cannabis and Cannabinoid Research (3 papers). Ben Watson collaborates with scholars based in United Kingdom, France and Netherlands. Ben Watson's co-authors include Anne Lingford‐Hughes, David Nutt, Paul Stokes, Alice Egerton, Nicola J. Kalk, Alistair Reid, Rosanna Michalczuk, Kit Wu, Luke Clark and Henrietta Bowden‐Jones and has published in prestigious journals such as NeuroImage, Journal of Cerebral Blood Flow & Metabolism and Psychopharmacology.

In The Last Decade

Ben Watson

13 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ben Watson United Kingdom	11	281	143	113	109	87	13	433
S. J. A. Boddington United Kingdom	8	178 0.6×	244 1.7×	56 0.5×	71 0.7×	105 1.2×	10	521
Arian Behzadi Canada	5	280 1.0×	84 0.6×	101 0.9×	45 0.4×	79 0.9×	6	375
Susan E. Best United States	9	256 0.9×	123 0.9×	37 0.3×	39 0.4×	80 0.9×	12	396
Chih-Ken Chen Taiwan	10	187 0.7×	70 0.5×	55 0.5×	85 0.8×	183 2.1×	13	429
Jennifer E. Learn United States	7	271 1.0×	142 1.0×	32 0.3×	52 0.5×	62 0.7×	10	441
Daniela A. Riaño Barros United Kingdom	12	177 0.6×	76 0.5×	35 0.3×	123 1.1×	77 0.9×	18	348
Helga Welzel Germany	7	248 0.9×	175 1.2×	41 0.4×	245 2.2×	72 0.8×	8	542
Linda Doty United States	5	254 0.9×	66 0.5×	74 0.7×	37 0.3×	51 0.6×	7	450
Yasmin Mashhoon United States	14	212 0.8×	212 1.5×	26 0.2×	76 0.7×	39 0.4×	18	405
Jenessa S. Price United States	10	121 0.4×	120 0.8×	51 0.5×	286 2.6×	108 1.2×	17	451

Countries citing papers authored by Ben Watson

Since Specialization

Citations

This map shows the geographic impact of Ben Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Watson more than expected).

Fields of papers citing papers by Ben Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Watson. The network helps show where Ben Watson may publish in the future.

Co-authorship network of co-authors of Ben Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Watson. A scholar is included among the top collaborators of Ben Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Watson. Ben Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Padmanathan, Prianka, Harriet Forbes, Maria Theresa Redaniel, et al.. (2021). Self-harm and suicide during and after opioid agonist treatment among primary care patients in England: a cohort study. The Lancet Psychiatry. 9(2). 151–159. 9 indexed citations

Lingford‐Hughes, Anne, James F. Myers, Ben Watson, et al.. (2016). Using [11C]Ro15 4513 PET to characterise GABA-benzodiazepine receptors in opiate addiction: Similarities and differences with alcoholism. NeuroImage. 132. 1–7. 10 indexed citations

Stokes, Paul, James F. Myers, Nicola J. Kalk, et al.. (2014). Acute increases in synaptic GABA detectable in the living human brain: A [11C]Ro15-4513 PET study. NeuroImage. 99. 158–165. 43 indexed citations

Watson, Ben, Lindsay G. Taylor, Sue Wilson, et al.. (2013). Investigating expectation and reward in human opioid addiction with [ ¹¹ C ]raclopride PET. Addiction Biology. 19(6). 1032–1040. 22 indexed citations

Stokes, Paul, Jim Myers, David Erritzøe, et al.. (2012). History of cigarette smoking is associated with higher limbic GABAA receptor availability. NeuroImage. 69. 70–77. 20 indexed citations

Clark, Luke, Paul Stokes, Kit Wu, et al.. (2012). Striatal dopamine D2/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity. NeuroImage. 63(1). 40–46. 109 indexed citations

Myers, James F., Lula Rosso, Ben Watson, et al.. (2012). Characterisation of the Contribution of the GABA-Benzodiazepine α1 Receptor Subtype to [¹¹C]Ro15-4513 PET Images. Journal of Cerebral Blood Flow & Metabolism. 32(4). 731–744. 27 indexed citations

Watson, Ben, Sarah J. Wilson, Lewis D. Griffin, et al.. (2011). A pilot study of the effectiveness of d-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects. Psychopharmacology. 216(1). 121–129. 28 indexed citations

Stokes, Paul, Alice Egerton, Ben Watson, et al.. (2011). History of cannabis use is not associated with alterations in striatal dopamine D₂/D₃ receptor availability. Journal of Psychopharmacology. 26(1). 144–149. 48 indexed citations

10.

Stokes, Paul, Alice Egerton, Ben Watson, et al.. (2010). Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge. NeuroImage. 52(4). 1521–1527. 59 indexed citations

11.

Lingford‐Hughes, Anne, et al.. (2010). Neuropharmacology of addiction and how it informs treatment. British Medical Bulletin. 96(1). 93–110. 24 indexed citations

12.

Daglish, Mark, Matthew J. Kempton, Tom A. Williams, et al.. (2007). Reduced thalamic grey matter volume in opioid dependence is influenced by degree of alcohol use: a voxel-based morphometry study. Journal of Psychopharmacology. 22(1). 7–10. 26 indexed citations

13.

Watson, Ben & Anne Lingford‐Hughes. (2007). Pharmacological treatment of addiction. Psychiatry. 6(7). 309–312. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact